封面
市场调查报告书
商品编码
1764139

细胞分离市场-全球产业规模、份额、趋势、机会和预测(按细胞类型、应用、地区和竞争细分,2020-2030 年)

Cell Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cell Type, By Application, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年,全球细胞分离市场规模为34.7亿美元,预计2030年将达到47.6亿美元,复合年增长率为5.62%。细胞分离是指从混合细胞群分离特定类型细胞的过程,是再生医学、癌症研究、免疫疗法和干细胞生物学等领域的基础。随着生命科学领域的发展,对高纯度和活细胞的需求推动了对能够提高细胞分离精度、可扩展性和效率的技术的投资增加。

市场概览
预测期 2026-2030
2024年市场规模 34.7亿美元
2030年市场规模 47.6亿美元
2025-2030 年复合年增长率 5.62%
成长最快的领域 人类细胞
最大的市场 北美洲

个人化医疗的日益普及是主要的成长动力,这种医疗依赖分离患者特异性细胞以开发标靶疗法。这种需求在肿瘤学领域尤其突出,因为免疫疗法和细胞疗法需要精准的细胞筛选。儘管高昂的成本和技术障碍构成挑战——尤其是在分离稀有或脆弱细胞类型方面——但亚太地区新兴市场正在创造新的扩张机会,这得益于医疗基础设施、研究能力和製药製造领域不断增长的投资。

关键市场驱动因素

医疗保健产业的成长

主要市场挑战

细胞分离技术成本高昂

主要市场趋势

对细胞疗法的需求增加

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:COVID-19 对全球细胞分离市场的影响

第五章:全球细胞分离市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依细胞类型(人类细胞、动物细胞)
    • 按应用(生物分子分离、癌症研究、干细胞研究、体外诊断、其他)
    • 按地区
    • 按公司分类(2024)
  • 市场地图

第六章:北美细胞分离市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章:欧洲细胞分离市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章:亚太细胞分离市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章:南美细胞分离市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东与非洲细胞分离市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 合併与收购(如有)
  • 产品发布(如有)
  • 最新动态

第十三章:干扰:衝突、流行病与贸易壁垒

第 14 章:全球细胞分离市场:SWOT 分析

第 15 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 16 章:竞争格局

  • Becton, Dickinson & Company
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Terumo Corporation
  • PluriSelect Life Science UG & Co. KG
  • Danaher Corporation
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences Inc.

第 17 章:策略建议

第18章调查会社について・免责事项

简介目录
Product Code: 5108

The Global Cell Isolation Market was valued at USD 3.47 billion in 2024 and is projected to reach USD 4.76 billion by 2030, expanding at a CAGR of 5.62%. Cell isolation-the process of separating specific cell types from a mixed population-is fundamental in fields such as regenerative medicine, cancer research, immunotherapy, and stem cell biology. As the life sciences sector advances, the demand for high-purity and viable cells is driving increased investment in technologies that offer enhanced precision, scalability, and efficiency in cell separation.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.47 Billion
Market Size 2030USD 4.76 Billion
CAGR 2025-20305.62%
Fastest Growing SegmentHuman Cells
Largest MarketNorth America

A primary growth driver is the growing adoption of personalized medicine, which depends on isolating patient-specific cells for the development of targeted therapies. This need is particularly prominent in oncology, where immunotherapies and cell-based treatments require accurate cell selection. While high costs and technical barriers pose challenges-especially in isolating rare or delicate cell types-emerging markets in the Asia-Pacific region are creating new opportunities for expansion, supported by growing investments in healthcare infrastructure, research capabilities, and pharmaceutical manufacturing.

Key Market Drivers

Growth in Healthcare Industry

The expansion of the global healthcare industry is a central factor driving the growth of the cell isolation market. With annual revenues exceeding USD 4 trillion, healthcare is supported by key sectors such as pharmaceuticals and biotechnology, contributing nearly USD 850 billion, and medical technology and diagnostics, which account for over USD 400 billion. This industry growth-especially in emerging economies-is accelerating the adoption of advanced diagnostic and therapeutic tools, including cell-based solutions.

As hospitals, laboratories, and pharmaceutical firms increasingly invest in regenerative therapies and precision medicine, the demand for scalable and reliable cell isolation techniques is rising. Additionally, the increasing global prevalence of chronic illnesses, including cancer and autoimmune diseases, has intensified the need for targeted therapies. In 2021, noncommunicable diseases were responsible for over 43 million deaths globally, with the majority occurring prematurely in low- and middle-income countries-reinforcing the importance of cell-based technologies for future treatment protocols.

Key Market Challenges

High Cost of Cell Isolation Technologies

The high cost associated with cell isolation technologies continues to be a major limitation for broader adoption, particularly in resource-limited settings. Systems like fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS) require sophisticated instruments, proprietary reagents, and specialized personnel, all contributing to significant operational costs.

These expenses present a substantial barrier for smaller laboratories, academic institutions, and biotech startups. Moreover, ongoing costs-such as maintenance, consumables, and technical support-can hinder the full utilization of cell isolation tools, especially in developing countries where funding and access to infrastructure are limited.

Key Market Trends

Increased Demand for Cell-Based Therapies

A key trend influencing the cell isolation market is the rising demand for cell-based therapies. By 2035, treatments such as CAR-T, TCR, and TIL therapies are expected to make up over 45% of clinical demand for cell therapy products. These therapies are gaining traction for their ability to address a wide array of diseases, including cancer, autoimmune conditions, and degenerative disorders.

This shift toward cell-based interventions is driving the need for robust isolation technologies that can reliably deliver high-quality, contamination-free, and functional cells. As the industry focuses more on precision medicine, the development and clinical use of cell therapies require advanced systems capable of delivering consistent and reproducible results in complex workflows.

Key Market Players

  • Becton, Dickinson & Company
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Terumo Corporation
  • PluriSelect Life Science UG & Co. KG
  • Danaher Corporation
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences Inc.

Report Scope

In this report, the Global Cell Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Isolation Market, By Cell Type:

  • Human Cells
  • Animal Cells

Cell Isolation Market, By Application:

  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • In Vitro Diagnostics
  • Others

Cell Isolation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Isolation Market.

Available Customizations

Global Cell Isolation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Cell Isolation Market

5. Global Cell Isolation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Cell Type (Human Cells, Animal Cells)
    • 5.2.2. By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Cell Isolation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Cell Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Isolation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Cell Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Cell Isolation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Cell Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Cell Isolation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Cell Type
        • 6.3.3.2.2. By Application

7. Europe Cell Isolation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Cell Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Cell Isolation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Cell Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Cell Isolation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Cell Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Cell Isolation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Cell Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Cell Isolation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Cell Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Cell Isolation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Cell Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Cell Isolation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Cell Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cell Isolation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Cell Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Cell Isolation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Cell Type
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Cell Isolation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Cell Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Cell Isolation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Cell Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Cell Isolation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Cell Type
        • 8.3.5.2.2. By Application

9. South America Cell Isolation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Cell Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cell Isolation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Cell Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Cell Isolation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Cell Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Cell Isolation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Cell Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Cell Isolation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Cell Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cell Isolation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Cell Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Cell Isolation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Cell Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Cell Isolation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Cell Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Cell Isolation Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Becton, Dickinson & Company
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Merck KGaA
  • 16.3. Thermo Fisher Scientific Inc.
  • 16.4. Bio-Rad Laboratories Inc.
  • 16.5. Terumo Corporation
  • 16.6. PluriSelect Life Science UG & Co. KG
  • 16.7. Danaher Corporation
  • 16.8. STEMCELL Technologies Inc.
  • 16.9. Corning Inc.
  • 16.10. Akadeum Life Sciences Inc.

17. Strategic Recommendations

18. About Us & Disclaimer